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Background: Age, gender and socioeconomic status have been shown to be associated with the use of prescription
drugs, even after adjustment for multimorbidity. General practitioners have a holistic and patient-centred perspective
and our hypothesis is that this may reflect on the prescription of drugs. In Sweden the patient may seek secondary care
without a letter of referral and the liability of the prescription of drugs accompanies the patient, which makes it suitable
for this type of research. In this study we examine the odds of having prescription drug use in the population and the
rates of prescription drugs among patients, issued in primary health care, according to age, gender and socioeconomic
status after adjustment for multimorbidity level.
Method: Data were collected on all individuals above 20 years of age in Östergötland county with about 400 000
inhabitants in year 2006. The John Hopkins ACG Case-mix was used as a proxy for multimorbidity level. Odds ratio (OR)
of having prescription drugs issued in primary health care in the population and rates of prescription drug use among
patients in primary health care, stated as incidence rate ratio (IRR), according to age, gender and socioeconomic status
were calculated and adjusted for multimorbidity.
Results: After adjustment for multimorbidity, individuals 80 years or older had higher odds ratio (OR 3.37 (CI 95%
3.22-3.52)) and incidence rate ratio (IRR 6.24 (CI 95% 5.79-6.72)) for prescription drug use. Male individuals had a lower
odds ratio of having prescription drugs (OR 0.66 (CI 95% 0.64-0.69)), but among patients males had a slightly higher
incidence rate of drug use (IRR 1.06 (CI 95% 1.04-1.09)). Individuals with the highest income had the lowest odds ratio
of having prescription drugs and individuals with the second lowest income had the highest odds ratio of having
prescription drugs (OR 1.10 (CI 95% 1.07-1.13)). Individuals with the highest education had the lowest odds ratio of
having prescription drugs (OR 0.61 (CI 95% 0.54-0.67)).
Conclusion: Age, gender and socioeconomic status are associated with large differences in the use of prescribed
drugs in primary health care, even after adjustment for multimorbidity level.
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Previous studies have shown that drugs are prescribed
unequally in the general population in Sweden, Europe,
Canada and in the United States [1-4]. Individuals with
low socioeconomic status use more prescription drugs
compared to individuals with high socioeconomic status
[5]. Males tend to use prescription drugs to a lower degree
compared to females [6]. High age tends to increase the
use of prescription drugs [7], even after adjustment for
multimorbidity level [8]. In the above comparisons
the prescribing of drugs in the total population has
been evaluated. Few studies have been performed that
only take into account the prescriptions issued by
physicians working in primary health care, i.e. general
practitioners (GPs).
Primary health care is performed in different socioeco-
nomic environments. General practitioners handle patients
with a holistic and patient-centred perspective and have a
unique insight into patients’ context and are accustomed to
consider differences in health [9]. Our hypothesis is that
this approach may have an influence on the prescription
of drugs. As in most Western European countries,
the first-line of health care in Sweden is primary
health care. In contrast to other Western Europeans
countries in Sweden the GPs do not have a gatekeeping
function. In case of health problems the individual cannot
handle him- or herself, he or she is supposed to get in
contact with his/her GP to get a primary evaluation of the
health status. In case the GP needs a second opinion or if
there is a need of larger resources to investigate the health
issue or disease, the GP refers to a specialist. Nevertheless,
the individual is allowed to seek secondary care, both at
the emergency room and at specialist clinics, without a
letter of referral. Only half of the patients who visit
Swedish health care meet a GP [10]. When the patient
seeks secondary care the liability regarding the prescription
of drugs accompanies the patient, regardless if the patient
was referred or not. Thus the prescription of drugs in
Sweden, in contrast to other Western European countries,
is divided between primary and secondary care, which
makes Sweden quite suitable for this type of research.
This study further enables us to compare the drug
prescriptions issued by all the physicians with the
drug prescriptions issued only by GPs. With respect
to the cost of prescription drugs this estimation is
furthermore of high interest. The use of prescription
drugs constitutes about 13% of the total cost of health care
in Sweden, and in most parts of Sweden the cost liability
for the drugs prescribed by the GPs is put on the
individual primary health care centres [11]. To be able to
affect the prescribing of drugs it is fundamental to know
how drugs are prescribed in primary health care, and it is
important to know about differences in drug prescribing
between various groups.The aim of this study was to investigate the odds of
having prescription drugs among individuals in the
population treated by GPs, and the rate of prescription
drug use among patients treated by GPs depending on




Data were collected in 2006 from the total population aged
20 years or older in Östergötland county with about 400
000 residents. Östergötland county is situated 200 km
southwest of Stockholm, and the age demography match
corresponds to that of the rest of Sweden [12]. Data on the
population’s age, gender and diagnoses in both primary
and secondary care were obtained through the Care Data
Warehouse in Östergötland (CDWÖ). The data in this
register hold information on both public and private
care. Information on this register has been described
earlier [13]. The study was approved by the Research
Ethics Committee at Linköping University (Dnr 147/
05 and 29/06).
Independent variables
Multimorbidity level was calculated using the Johns
Hopkins Adjusted Clinical Groups (ACG) Case-Mix
System, a system based on the theory that multimorbidity
level corresponds to a certain need for healthcare resources.
This system is based on the patients’ diagnoses, from both
primary and secondary care, recorded during a defined
period of time. Etiology, duration, method of diagnosis,
treatment and need of specialised care are considered for
each of the patients’ diagnoses. The ACG Case-Mix System
has previously been described [14-17]. Individuals without
need of health care according to the ACG Case-Mix system
are placed in Resource Utilization Band 0 (RUB 0), and
individuals with a very high degree of need for healthcare
resources are placed in RUB 5.
We used income and education as our socioeconomic
variables. The individual disposable income was divided
into quartiles, from the lowest to the highest with equal
number of individuals in each quartile. The individual
income includes earnings from employment and business,
and income transfers (e.g., pension payments, unemploy-
ment benefits, or paid sick leave) but not capital returns.
The education variable was divided into four levels: 1.
Primary school not completed (<9 years), 2. Primary school
completed (9–10 years), 3. Secondary school (10–12 years),
and 4. Higher education (>12 years). Information on
individual level of income and education was obtained from
Statistics Sweden. Information on educational level was to
a high degree missing in people 70 years or older, therefore
this group was excluded when the effect of educational
level on prescription drug use was analysed.
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The utilisation of prescription drugs, stated as Defined
Daily Doses (DDDs), in 2006 issued by a GP was the
dependent variable. Information concerning the use of
prescription drugs on the individual level was acquired
from the Swedish Prescribed Drug Register at the National
Board of Health and Welfare [18]. This register collects
the information from the National Corporation of Swedish
Pharmacies (Apoteket AB). At the time of the study
Apoteket AB had a monopoly on sales of prescription
drugs, and all prescription drugs were tracked through
Apoteket AB. DDD is defined by WHO as the assumed
average maintenance dose per day for a drug used for
its main indication in adults. It is a fixed unit of
measurement that enables comparative research on
prescription drugs [19]. Over the counter drugs were
not included in this study.
Statistics
We used STATA version 12 (Stata Corporation, Texas,
USA) for statistical analyses. The best statistical model
to define the data was considered to be zero-inflated
negative binomial regression, since this model takes into
account that a high number in the population do not use
prescription drugs [20]. This model performs two analyses
in parallel. One analysis is similar to logistic regression
and answers the question on what the odds are for the
individual to belong to the population with prescription
drugs issued by GPs. This analysis gives odds ratios (OR).
The other analysis is similar to Poisson regression and
answers the question of what the effect is of increasing the
independent variable, i.e. DDD, with one unit for the
individuals who already have at least one DDD. This ana-
lysis gives an incident rate ratio (IRR). We generated two
different models; Model 1 was adjusted for gender, age, mul-
timorbidity (RUB) and income, and Model 2 was adjusted
for gender, age, multimorbidity (RUB) and education.
In order to examine if the differences in the prescrip-
tion of drugs were dependent on the primary healthcare
centres (PHC), we performed a multi-level analysis. The
analysis showed that only about 2% of the differences
seen between various groups was dependent on the PHC
level.
Due to possible interaction between the variables
education and income we have analysed the data for
each educational level, comprising individuals up to
70 years old. We have also analysed the data for each
age level due to possible interaction between age and
multimorbidity level.
In the following sections, when we refer to odds ratios
we mean individuals in the population, i.e. people both
with and without prescription drugs, and when we refer
to incidence rate ratios we mean patients, i.e. people that
already have at least one prescription drug.Results
The study comprised 313 977 individuals with an even sex
distribution. A total of 46% had at least one prescription
drug issued by a GP. About 231 million DDDs were
collected from the pharmacies. Further characteristics
of the study population are described in Table 1.Age
After adjustment for multimorbidity level, gender and
income, age increased the odds ratios of having prescrip-
tions drugs issued by GPs in the population, and it also
increased the rate of prescription drug use among patients
(Tables 2 and 3).Gender
Males had lower odds ratio of having prescription drugs
issued by GPs compared to females after adjustment for
multimorbidity level, age and income (OR 0.66 (95% CI
0.64-0.69)) or education (OR 0.63 (95% CI 0.60-0.66))
(Table 2). The rates of prescription drug use were higher
for male patients after adjustment for multimorbidity
level, age and income (IRR 1.06 (95% CI 1.04-1.09)). The
rates of prescription drug use were the same between
the genders after adjustment for multimorbidity, age and
education (IRR 0.99 (95% CI 0.96-1.02)) (Table 3).Income
Individuals with the highest level of income had the
lowest odds ratio of having prescription drugs issued
by GPs after adjustment for multimorbidity level, gender
and age (OR 0.86 (95% CI 0.81-0.91)). Individuals with the
second lowest level of income had the highest odds ratio
of having prescription drugs (OR 1.10 (95% CI 1.07-1.13)
and the individuals with the lowest level of income had
the second highest odds ratio of having prescription drugs
issued by GPs (Table 2). The result was nearly the same
for the rates of prescription drug use among patients with
the exception of that the patients with the lowest and the
second lowest income level together had the lowest rates
of prescription drug use (Table 3).Education
Individuals with the lowest level of education had the
highest odds ratio of having prescription drugs issued by
GPs after adjustment for multimorbidity level, gender
and age. The odds ratios decreased with increasing
levels of education with the lowest odds ratio of having
prescription drugs at the highest level of education
(OR 0.61 (95% CI 0.54-0.67). The associations were
the same for the rates of prescription drug use among
patients (Tables 2 and 3).
Table 1 Characteristics of the study population’s drug use
Collected prescription drugs in the total population Collected prescription drugs in the total
population issued by general practitioner
Yes No Yes No
Variables N (%) N (%) N (%) N (%)
All 205827 (66) 108150 (34) 145126 (46) 168851 (54)
Gender
Female 121682 (77) 37021 (23) 85102 (54) 73601 (46)
Male 84145 (54) 71129 (46) 60024 (39) 95250 (61)
Age
20-39 51582 (52) 47857 (48) 25953 (74) 73486 (26)
40-59 65365 (60) 43338 (40) 44584 (41) 64119 (59)
60-79 64388 (81) 15414 (19) 52494 (34) 27308 (66)
80- 24492 (94) 1541 (6) 22095 (85) 3938 (15)
Multimorbidity level
0 26822 (26) 75013 (74) 16657 (16) 85178 (84)
1 30364 (69) 13491 (31) 17594 (40) 26261 (60)
2 51674 (80) 12913 (20) 35401 (55) 29186 (45)
3 82988 (93) 6595 (7) 63432 (71) 26151 (29)
4 10775 (99) 126 (1) 9196 (84) 1705 (16)
5 3204 (99.6) 12 (0.4) 2846 (88) 370 (12)
Income level
1 (low) 55260 (70) 23185 (30) 40986 (52) 37459 (48)
2 59030 (75) 19415 (25) 43876 (56) 34569 (44)
3 48816 (62) 29630 (38) 32426 (41) 46020 (59)
4 (high) 42720 (55) 35724 (45) 27837 (35) 50607 (65)
Educational level*
1 (low) 15377 (73) 5732 (27) 12166 (58) 8943 (42)
2 16292 (62) 10003 (38) 11070 (42) 15225 (58)
3 74886 (60) 50695 (40) 48366 (39) 77215 (61)
4 (high) 45296 (56) 35001 (44) 26552 (33) 53745 (67)
N – Number of observations.
*Including individuals up to 70 years old.
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Individuals with the lowest level of income had the low-
est odds ratio of having prescription drugs if they
belonged to educational level 2 or above. The rates of
prescription drug use in every income level followed the
same pattern as in Model 1 when the data was analysed
for each educational level (Additional file 1: Table S1).
The odds ratio of having prescription drugs and the
rate of prescription drug use showed nearly the same
pattern in every multimorbidity level in Model 1 when
the data was analysed for each age level besides that
both individuals and patients aged 20–39 in the highest
multimorbidity level had higher odds ratios of having
prescription drugs (OR 4.32 (95% CI 4.07-5.54) vs. OR
3.88 (95% CI 3.73-4.04)) and higher rates of prescriptiondrug use (IRR 3.99 (95% CI 1.88-8.45) vs. IRR 1.75 (95%
CI 1.63-1.86)) (Additional file 1: Table S2).
Discussion
In this study we have examined the use of prescription
drugs issued in primary health care according to age,
gender, income or education after adjustment for multi-
morbidity level. Our main findings were that age in-
creased the odds ratio of having prescription drugs,
despite adjustment for multimorbidity level. We found
that males had lower odds ratios of having prescription
drugs compared to females. The differences in the socio-
economic groups were also substantial, where people
with the highest income level had the lowest prescrip-
tion drug use and people with the second to lowest
Table 2 Odds ratios of having prescription drugs in the
population issued in primary health care
Variables OR (CI 95%) p-value OR (CI 95%)* p-value
Gender
Females 1 1
Males 0.66 (0.64-0.69) <0.001 0.63 (0.60-0.66) <0.001
Age
20-39 1 1
40-59 1.76 (1.72-1.79) <0.001 1.71 (1.68-1.75) <0.001
60-79 2.56 (2.49-2.62) <0.001 2.33 (2.27-2.39) <0.001
80- 3.37 (3.22-3.52) <0.001
Multimorbdity level
RUB 0 (low) 1 1
RUB 1 2.38 (2.32-2.44) <0.001 2.48 (2.42-2.54) <0.001
RUB 2 2.86 (2.79-2.93) <0.001 2.95 (2.88-3.02) <0.001
RUB 3 3.30 (3.21-3.39) <0.001 3.39 (3.30-3.48) <0.001
RUB 4 3.75 (3.63-3.87) <0.001 3.86 (3.75-3.97) <0.001
RUB 5 (high) 3.88 (3.73-4.04) <0.001 4.01 (3.79-4.22) <0.001
Income
1 (low) 1 -
2 1.10 (1.07-1.13) <0.001 -
3 0.98 (0.95-1.02) 0.375 -
4 (high) 0.86 (0.81-0.91) <0.001 -
Education
1 (low) - 1
2 - 0.85 (0.81-0.89) <0.001
3 - 0.77 (0.73-0.81) <0.001
4 (high) - 0.61 (0.54-0.67) <0.001
*Including individuals up to 70 years old.
Table 3 Incidence rate ratios of prescription drug use
among patients in primary health care
Variables IRR (CI 95%) p-value IRR (CI 95%)* p-value
Gender
Females 1 1
Males 1.06 (1.04-1.09) <0.001 0.99 (0.96-1.02) 0.674
Age
20-39 1 1
40-59 2.41 (2.31-2.52) <0.001 2.29 (2.19-2.39) <0.001
60-79 4.34 (4.12-4.57) <0.001 3.78 (3.62-3.96) <0.001
80- 6.24 (5.79-6.72) <0.001
Multimorbidity level
RUB 0 (low) 1 1
RUB 1 0.74 (0.71-0.78) <0.001 0.69 (0.66-0.73) <0.001
RUB 2 0.94 (0.90-0.98) 0.004 0.92 (0.88-0.97) 0.001
RUB 3 1.33 (1.29-1.37) <0.001 1.35 (1.30-1.41) <0.001
RUB 4 1.66 (1.58-1.74) <0.001 1.89 (1.74-2.05) <0.001
RUB 5 (high) 1.75 (1.63-1.86) <0.001 2.26 (2.00-2.55) <0.001
Income
1 (low) 1 -
2 1.00 (0.98-1.03) 0.811 -
3 0.78 (0.75-0.81) <0.001 -
4 (high) 0.70 (0.68-0.72) <0.001 -
Education
1 (low) - 1
2 - 0.97 (0.91-1.02) 0.227
3 - 0.82 (0.80-0.85) <0.001
4 (high) - 0.70 (0.67-0.73) <0.001
*Including patients up to 70 years old.
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People with the lowest educational level had the highest
prescription drug use.
Age
The finding that age increased both the odds ratio of
having prescription drugs and the rate of prescription
drug use has previously been shown, when the total pre-
scribing of drugs has been examined [3]. In this study
we have only examined the prescription drugs issued in
primary health care, and despite the fact that we have
adjusted for multimorbidity level, higher age seems to
lead to higher use of prescription drugs.
GPs may have different approaches to treatment of
patients with a new diagnosis depending on age. It is prob-
ably more likely that younger people with a new diagnosis
of for example hypertension are recommended changes in
lifestyle, while older people may be more likely to be
recommended a prescription drug. This may partly explainhigher odds ratios of prescription drug use among the
elderly. Some diagnoses are progressive, for instance dia-
betes mellitus, where worsening is expected with higher age
[21]. Under these circumstances increasing prescription
drug use among elderly is expected and may partly explain
the higher rate of prescription drug use among the patients.
The prescribing cascade may help to explain, why the
elderly use more prescription drugs despite adjustment for
multimorbidity level. The prescribing cascade is described
to start as an adverse drug reaction that is misinterpreted
as a new diagnosis. A new drug is prescribed to treat this
“new” diagnosis, and at worst an adverse drug reaction
against the new prescription drug is once again misinter-
preted as a new diagnosis and another drug is prescribed
[22]. With higher age and more diagnoses it is more likely
that the elderly are put at risk of this prescribing cascade.
The above may to some extent explain why the elderly have
higher odds ratios and rate of prescription drug use, which
calls for better quality in drug treatment in the elderly.
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drugs according to age is less prominent, when prescrip-
tion drugs issued in primary health care are compared
with prescription drugs in the total population [8]. Since
many elderly with chronic diseases are treated in pri-
mary health care in Sweden, we would rather expect that
the differences would be greater in primary health care
compared to studies where the total population was ex-
amined. It could be that GPs have a more holistic
approach and that GPs are better at evaluating prescrip-
tion drugs [23]. It could also be that GPs to a lower ex-
tent tend to follow treatment guidelines [24].Gender
Males had significantly lower odds ratio of having prescrip-
tion drugs compared to females, despite adjustment for
multimorbidity level. This situation has been shown before
in studies carried out on the total population [6,25], but
rarely with adjustment for multimorbidity level and rarely
only in a primary healthcare population.
Females tend to utilise health care more often than
males [26], which may partly explain the gender difference.
Females also tend to seek more preventive care than males
[27], which may further contribute to the gender difference.
There is a gender difference in which diagnoses females
and males are diagnosed with, and a former study indicates
that this gender difference in morbidity may partly explain
the gender difference in odds of having prescription drugs
[28]. Former studies have shown that there is variability
between how physicians prescribe drugs and it is pos-
sible that this may affect the gender difference [29]. It
is puzzling that the odds ratio for males in the population
to have at least one prescription drug is quite low
(OR 0.66), while males among patients in parallel
have a higher rate of prescription drug use (IRR 1.06).
This could be interpreted as the barrier to initiate
prescription drug treatment being higher for males. It
is also possible that there is a gender difference in
compliance to drug treatment, which has been indicated
in some studies [30,31].
The gender difference regarding odds ratios of having
prescription drugs is less distinct when prescription drug
use issued in the primary health care is compared with
the total prescription drug use [8]. This could partly be
explained by the fact that in Sweden, at the time of the
study, oral contraceptive drugs were not prescribed by
GPs in primary health care, but mainly issued by midwives
belonging to secondary care.Income
Individuals and patients with the highest level of income
had the lowest odds ratio and rate of prescription drug
use issued in primary health care. Individuals with thesecond to lowest income had the highest odds ratio of
having prescription drugs.
Despite adjustment for multimorbidity level there are
substantial differences between the lowest and highest
levels of income in drug use in primary health care. This
is interesting since theses differences cannot be explained
by differences depending on multimorbidity level between
the different levels of income. Individuals with the lowest
level of income had not the highest but next to highest
odds ratio of having prescription drugs. This condition
may be interpreted as if the individuals with the lowest
level of income were unable to afford the prescribed
drug, which has been seen before [6]. In Sweden,
there is a high cost threshold system for prescription
drugs, which implicates that the patients do not pay more
than a defined amount for prescription drugs, SEK 2200
(EUR 248), annually. Despite this benefit system, it may be
interpreted in this study as both individuals and patients
with the lowest level of income did not purchase their
prescribed drugs issued in primary health care.
The difference between the different income levels
in odds ratio of having prescription drugs was larger
when prescriptions issued by only GPs were examined
compared to the differences seen in another of our
studies where the prescription of drugs in the total
population was examined [8]. This indicates that there is a
social gradient in the way primary health care is provided.
Education
Individuals and patients with the lowest level of education
had the highest odds ratio and rate of prescription drug
use issued in primary health care.
Former studies have shown that individuals with lower
socioeconomic status appear to a lesser extent to act on
information regarding health risks, e.g. smoking [32]. In
many of our common chronic diseases, e.g. diabetes, hyper-
tension and hyperlipidaemia, lifestyle changes are a first
point of action, and if individuals with lower socioeconomic
status do not act on the physicians’ recommendations of
lifestyle changes, this may lead to both higher odds ratio
and rate of drug use. Utilisation of health care differs ac-
cording to socioeconomic status with a higher consultation
rate among individuals with low socioeconomic status [33].
This may lead to increased odds ratio of having prescription
drugs among individuals with lower socioeconomic status.
The difference between the different educational levels
in odds ratio of having prescription drugs was also larger
when prescription drugs issued by only GPs was examined
compared to when the prescription of drugs in the total
population was examined [8].
Interactions
When data were analysed for each educational level
the rate of prescription drug use among patients in
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Model 1. This means that also at different educational
levels the income level still affects the rate of prescription
drug use among patients.
Individuals with the lowest income level had the lowest
odds ratio of having prescription drugs if they belonged to
educational level 2 or above. This means that the poorest
individuals use drugs to a lesser extent if they have
completed only primary school. This elucidates further
that there is a social gradient in the way primary health
care is provided.
Limitations
ACG Case-Mix uses diagnoses to calculate multimorbidity
level. It is, therefore, dependent on the quality of registration
of diagnoses. The recording of diagnoses was not validated
in this study, but a former study in Sweden has shown that
75% of the population have at least one diagnosis-registered
encounter with a GP during a three-year period [34].
Even if all the prescription drugs in this study were issued
in primary health care, some of the prescriptions were
probably originally initiated in secondary care. That is,
some of the prescriptions are probably iterations from
secondary care and hence do not necessarily entirely reflect
the prescribing of drugs in primary care.
In this study we examined the prescription drugs that
were collected from the pharmacies and not the prescrip-
tion drugs that were actually prescribed by the doctors. If
the compliance was inadequate, the collection of drugs
does not adequately reflect the prescribing of drugs.
We were not able to assess illicit drug use, and these
drugs were not included in this study.
It would have been interesting to include the level of
general practitioners in the multi-level analysis but in
the Swedish Prescribed Drugs Register we had access
only to data down to Primary Health Care Centre level.
Conclusion
There is a large difference in prescription drug use with
regard to age, gender and socioeconomic status in primary
health care after adjustment for multimorbidity. This
implicates that the prescription drug use is not equal in
society, and that factors other than medical ones affect the
prescribing of drugs. This should be emphasised to both
decision-makers and medical staff.Additional file
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